Clearwater Paper Q4 net loss from continuing ops $74M; total net income boosted by tissue sale gain

Clearwater Paper Corp

2024-FY EPS reported $11.70 revenue$1,383,600,000

Net loss from continuing ops $74M ($4.41 diluted loss) vs net income $49M in 2023; total net income $196M includes $307M gain on tissue sale.
Net sales from continuing ops $1.4B up 22% YoY on Augusta acquisition; paperboard prices down 12% to $1,210/ton for full year.
Q4 Adjusted EBITDA from total ops $21M vs $63M last year; full year $182M vs $281M on lower pricing and higher maintenance.
Plans to cut >10% of positions, targeting $30-40M cost savings in 2025.
Completed sale of tissue business for $1.06B on Nov 1, 2024; reduced net debt by $199M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.